{
    "code": "02024795",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024795",
    "time": "2021-10-08 07:28:54",
    "許可證字號": "衛署藥輸字第024795號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/03\/03",
    "發證日期": "97\/03\/03",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202479502",
    "中文品名": "納衛視點眼懸液劑 0.1%",
    "英文品名": "Nevanac Ophthalmic suspension 0.1%",
    "適應症": "治療白內障手術引起之疼痛與發炎。",
    "劑型": "483點眼懸液劑",
    "包裝": "100毫升以下塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "NEPAFENAC",
    "限制項目": "02輸　入 55依本署89、12、12衛署藥字第0890035812號公告事項三經本署認定得免除銜接性試驗之新藥",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "": "UNITED STATES",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808408700",
            "成分名稱": "NEPAFENAC",
            "含量描述": "",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "024795_Natacyn 5% Ophthalmic Suspension-108-06-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024795&Seq=002&Type=10"
        },
        {
            "title": "Picture_Nevanac-104-10-01(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024795&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Upload_9017601_TW_p1_LFT_X-4-109-01-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024795&Seq=009&Type=9"
        },
        {
            "title": "2.0_cSLT_NEVANAC (TWI-270618)-107-07-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024795&Seq=008&Type=9"
        },
        {
            "title": "Upload_H15641_TW_p1_LBL_X-4-109-01-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024795&Seq=013&Type=8"
        },
        {
            "title": "Upload_9017602_TW_p1_FB_X-4-109-01-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024795&Seq=012&Type=8"
        },
        {
            "title": "NEVANAC_H14925_TW_p1_LBL_X-4 for upload-107-02-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024795&Seq=011&Type=8"
        },
        {
            "title": "NEVANAC_9014948_TW_p1_FB_X-4 for uplaod-107-02-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024795&Seq=010&Type=8"
        }
    ]
}